Infection in OKT3-treated patients receiving additional antirejection therapy.
Munda
R
R
Department of Surgery, University of Cincinnati College of Medicine, Ohio 45267-0558.
Hutchins
M
M
First
M R
MR
Carey
M
M
Schroeder
T
T
Alexander
J W
JW
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology*; D002177:Candidiasis / Q000209:etiology; D002986:Clinical Trials as Topic; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D014777:Virus Diseases / Q000209:etiology*
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents